Amlodipine 5 MG / atorvastatin 20 MG Oral Tablet — RxCUI 597980
RxNorm drug concept · Semantic clinical drug
RxCUI 597980
Semantic clinical drug · SCD
● Current RxNorm concept 75 FDA products
130 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI597980
Official nameAmlodipine 5 MG / atorvastatin 20 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asamlodipine (as amlodipine besylate) 5 MG / atorvastatin (as atorvastatin calcium) 20 MG Oral Tablet; amLODIPine besylate 5 MG / atorvastatin calcium 20 MG Oral Tablet
FDA products mapped75
Package NDCs mapped130
Reported Medicaid activity (SDUD)1,473 prescriptions · 6 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Atorvastatin: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- It mainly lowers your LDL — the "bad" cholesterol — and triglycerides, while nudging your HDL ("good" cholesterol) a little higher. Over time, keeping those numbers in a healthier...
- What exactly is atorvastatin supposed to do for me?
- Honestly, no — the cholesterol-lowering effect is the same whether you take it in the morning or at night, and whether you eat beforehand or not. The most important thing is that y...
- Does it matter what time of day I take it, or whether I eat first?
🕸️ Concept Web — How Amlodipine 5 MG / atorvastatin 20 MG Oral Tablet Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Amlodipine 5 MG / atorvastatin 20 MG Oral Tablet
RxCUI 597980 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 3
The active substance itself — no strength, form, or brand attached yet.
-
Amlodipine
17767IN -
Atorvastatin
83367IN -
Amlodipine / atorvastatin
404773MIN
-
Amlodipine
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Caduet
404914BN
-
Caduet
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Amlodipine / atorvastatin Oral Tablet
405788SCDF -
Amlodipine / atorvastatin Oral Product
1152281SCDG -
Amlodipine / atorvastatin Pill
1152282SCDG -
Amlodipine / atorvastatin Oral Tablet [Caduet]
750218SBDF -
Caduet Oral Product
1170193SBDG -
Caduet Pill
1170826SBDG -
Oral Tablet
317541DF -
Oral Product
1151131DFG - +1 more in this family
-
Amlodipine / atorvastatin Oral Tablet
-
Clinical & branded drugs 4
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Amlodipine 5 MG
329528SCDC -
Atorvastatin 20 MG
597966SCDC -
Amlodipine 5 MG / atorvastatin 20 MG Oral Tablet [Caduet]
750231SBD -
Amlodipine 5 MG / atorvastatin 20 MG [Caduet]
750229SBDC
-
Amlodipine 5 MG
Showing up to 8 concepts per family — 16 of 17 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Amlodipine 5 MG
SCDC · 329528 -
Atorvastatin 20 MG
SCDC · 597966 -
Amlodipine / atorvastatin Oral Tablet
SCDF · 405788 -
Amlodipine / atorvastatin Oral Product
SCDG · 1152281 -
Amlodipine / atorvastatin Pill
SCDG · 1152282
Brand-Name Concepts
-
Amlodipine 5 MG / atorvastatin 20 MG Oral Tablet [Caduet]
SBD · 750231 -
Amlodipine 5 MG / atorvastatin 20 MG [Caduet]
SBDC · 750229 -
Amlodipine / atorvastatin Oral Tablet [Caduet]
SBDF · 750218 -
Caduet Oral Product
SBDG · 1170193 -
Caduet Pill
SBDG · 1170826 -
Caduet
BN · 404914
📦 FDA Products & Package NDCs
75 products · 130 package NDCs
130 package NDCs map to RxCUI 597980 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 43598-0321-60 | 60 TABLET, FILM COATED in 1 BOTTLE (43598-321-60) | Amlodipine besylate and Atorvastatin calcium | Dr. Reddy's Laboratories Inc | 2014-03-17 |
| 43598-0321-90 | 90 TABLET, FILM COATED in 1 BOTTLE (43598-321-90) | Amlodipine besylate and Atorvastatin calcium | Dr. Reddy's Laboratories Inc | 2014-03-17 |
| 43598-0322-05 | 500 TABLET, FILM COATED in 1 BOTTLE (43598-322-05) | Amlodipine besylate and Atorvastatin calcium | Dr. Reddy's Laboratories Inc | 2014-03-17 |
| 43598-0322-30 | 30 TABLET, FILM COATED in 1 BOTTLE (43598-322-30) | Amlodipine besylate and Atorvastatin calcium | Dr. Reddy's Laboratories Inc | 2014-03-17 |
| 43598-0322-60 | 60 TABLET, FILM COATED in 1 BOTTLE (43598-322-60) | Amlodipine besylate and Atorvastatin calcium | Dr. Reddy's Laboratories Inc | 2014-03-17 |
| 43598-0322-90 | 90 TABLET, FILM COATED in 1 BOTTLE (43598-322-90) | Amlodipine besylate and Atorvastatin calcium | Dr. Reddy's Laboratories Inc | 2014-03-17 |
| 43598-0323-05 | 500 TABLET, FILM COATED in 1 BOTTLE (43598-323-05) | Amlodipine besylate and Atorvastatin calcium | Dr. Reddy's Laboratories Inc | 2014-03-17 |
| 43598-0323-30 | 30 TABLET, FILM COATED in 1 BOTTLE (43598-323-30) | Amlodipine besylate and Atorvastatin calcium | Dr. Reddy's Laboratories Inc | 2014-03-17 |
| 43598-0323-60 | 60 TABLET, FILM COATED in 1 BOTTLE (43598-323-60) | Amlodipine besylate and Atorvastatin calcium | Dr. Reddy's Laboratories Inc | 2014-03-17 |
| 43598-0323-90 | 90 TABLET, FILM COATED in 1 BOTTLE (43598-323-90) | Amlodipine besylate and Atorvastatin calcium | Dr. Reddy's Laboratories Inc | 2014-03-17 |
| 46708-0755-30 | 30 TABLET, FILM COATED in 1 BOTTLE (46708-755-30) | Amlodipine and Atorvastatin | Alembic Pharmaceuticals Limited | 2025-05-23 |
| 46708-0755-90 | 90 TABLET, FILM COATED in 1 BOTTLE (46708-755-90) | Amlodipine and Atorvastatin | Alembic Pharmaceuticals Limited | 2025-05-23 |
| 46708-0756-30 | 30 TABLET, FILM COATED in 1 BOTTLE (46708-756-30) | Amlodipine and Atorvastatin | Alembic Pharmaceuticals Limited | 2025-05-23 |
| 46708-0756-90 | 90 TABLET, FILM COATED in 1 BOTTLE (46708-756-90) | Amlodipine and Atorvastatin | Alembic Pharmaceuticals Limited | 2025-05-23 |
| 46708-0757-30 | 30 TABLET, FILM COATED in 1 BOTTLE (46708-757-30) | Amlodipine and Atorvastatin | Alembic Pharmaceuticals Limited | 2025-05-23 |
| 46708-0757-90 | 90 TABLET, FILM COATED in 1 BOTTLE (46708-757-90) | Amlodipine and Atorvastatin | Alembic Pharmaceuticals Limited | 2025-05-23 |
| 46708-0758-30 | 30 TABLET, FILM COATED in 1 BOTTLE (46708-758-30) | Amlodipine and Atorvastatin | Alembic Pharmaceuticals Limited | 2025-05-23 |
| 46708-0758-90 | 90 TABLET, FILM COATED in 1 BOTTLE (46708-758-90) | Amlodipine and Atorvastatin | Alembic Pharmaceuticals Limited | 2025-05-23 |
| 46708-0759-30 | 30 TABLET, FILM COATED in 1 BOTTLE (46708-759-30) | Amlodipine and Atorvastatin | Alembic Pharmaceuticals Limited | 2025-05-23 |
| 46708-0759-90 | 90 TABLET, FILM COATED in 1 BOTTLE (46708-759-90) | Amlodipine and Atorvastatin | Alembic Pharmaceuticals Limited | 2025-05-23 |
| 46708-0760-30 | 30 TABLET, FILM COATED in 1 BOTTLE (46708-760-30) | Amlodipine and Atorvastatin | Alembic Pharmaceuticals Limited | 2025-05-23 |
| 46708-0760-90 | 90 TABLET, FILM COATED in 1 BOTTLE (46708-760-90) | Amlodipine and Atorvastatin | Alembic Pharmaceuticals Limited | 2025-05-23 |
| 46708-0761-30 | 30 TABLET, FILM COATED in 1 BOTTLE (46708-761-30) | Amlodipine and Atorvastatin | Alembic Pharmaceuticals Limited | 2025-05-23 |
| 46708-0761-90 | 90 TABLET, FILM COATED in 1 BOTTLE (46708-761-90) | Amlodipine and Atorvastatin | Alembic Pharmaceuticals Limited | 2025-05-23 |
| 46708-0762-30 | 30 TABLET, FILM COATED in 1 BOTTLE (46708-762-30) | Amlodipine and Atorvastatin | Alembic Pharmaceuticals Limited | 2025-05-23 |
| 46708-0762-90 | 90 TABLET, FILM COATED in 1 BOTTLE (46708-762-90) | Amlodipine and Atorvastatin | Alembic Pharmaceuticals Limited | 2025-05-23 |
| 46708-0763-30 | 30 TABLET, FILM COATED in 1 BOTTLE (46708-763-30) | Amlodipine and Atorvastatin | Alembic Pharmaceuticals Limited | 2025-05-23 |
| 46708-0763-90 | 90 TABLET, FILM COATED in 1 BOTTLE (46708-763-90) | Amlodipine and Atorvastatin | Alembic Pharmaceuticals Limited | 2025-05-23 |
| 46708-0764-30 | 30 TABLET, FILM COATED in 1 BOTTLE (46708-764-30) | Amlodipine and Atorvastatin | Alembic Pharmaceuticals Limited | 2025-05-23 |
| 46708-0764-90 | 90 TABLET, FILM COATED in 1 BOTTLE (46708-764-90) | Amlodipine and Atorvastatin | Alembic Pharmaceuticals Limited | 2025-05-23 |
| 46708-0765-30 | 30 TABLET, FILM COATED in 1 BOTTLE (46708-765-30) | Amlodipine and Atorvastatin | Alembic Pharmaceuticals Limited | 2025-05-23 |
| 46708-0765-90 | 90 TABLET, FILM COATED in 1 BOTTLE (46708-765-90) | Amlodipine and Atorvastatin | Alembic Pharmaceuticals Limited | 2025-05-23 |
| 58151-0062-93 | 30 TABLET, FILM COATED in 1 BOTTLE (58151-062-93) | Caduet | Viatris Specialty LLC | 2026-02-25 |
| 58151-0063-93 | 30 TABLET, FILM COATED in 1 BOTTLE (58151-063-93) | Caduet | Viatris Specialty LLC | 2026-02-25 |
| 58151-0064-93 | 30 TABLET, FILM COATED in 1 BOTTLE (58151-064-93) | Caduet | Viatris Specialty LLC | 2026-06-24 |
| 58151-0065-93 | 30 TABLET, FILM COATED in 1 BOTTLE (58151-065-93) | Caduet | Viatris Specialty LLC | 2026-02-25 |
| 58151-0066-93 | 30 TABLET, FILM COATED in 1 BOTTLE (58151-066-93) | Caduet | Viatris Specialty LLC | 2026-02-26 |
| 58151-0067-93 | 30 TABLET, FILM COATED in 1 BOTTLE (58151-067-93) | Caduet | Viatris Specialty LLC | 2026-02-26 |
| 60505-3478-03 | 30 TABLET, FILM COATED in 1 BOTTLE (60505-3478-3) | Amlodipine and Atorvastatin | Apotex Corp. | 2020-07-29 |
| 60505-3479-03 | 30 TABLET, FILM COATED in 1 BOTTLE (60505-3479-3) | Amlodipine and Atorvastatin | Apotex Corp. | 2020-07-29 |
| 60505-3483-03 | 30 TABLET, FILM COATED in 1 BOTTLE (60505-3483-3) | Amlodipine and Atorvastatin | Apotex Corp. | 2020-07-29 |
| 60505-3484-03 | 30 TABLET, FILM COATED in 1 BOTTLE (60505-3484-3) | Amlodipine and Atorvastatin | Apotex Corp. | 2020-07-29 |
| 60505-3488-03 | 30 TABLET, FILM COATED in 1 BOTTLE (60505-3488-3) | Amlodipine and Atorvastatin | Apotex Corp. | 2020-07-29 |
| 60505-3489-03 | 30 TABLET, FILM COATED in 1 BOTTLE (60505-3489-3) | Amlodipine and Atorvastatin | Apotex Corp. | 2020-07-29 |
| 60505-3492-03 | 30 TABLET, FILM COATED in 1 BOTTLE (60505-3492-3) | Amlodipine and Atorvastatin | Apotex Corp. | 2020-07-29 |
| 60505-3493-03 | 30 TABLET, FILM COATED in 1 BOTTLE (60505-3493-3) | Amlodipine and Atorvastatin | Apotex Corp. | 2020-07-29 |
| 62332-0755-30 | 30 TABLET, FILM COATED in 1 BOTTLE (62332-755-30) | Amlodipine and Atorvastatin | Alembic Pharmaceuticals Inc. | 2025-05-23 |
| 62332-0755-90 | 90 TABLET, FILM COATED in 1 BOTTLE (62332-755-90) | Amlodipine and Atorvastatin | Alembic Pharmaceuticals Inc. | 2025-05-23 |
| 62332-0756-30 | 30 TABLET, FILM COATED in 1 BOTTLE (62332-756-30) | Amlodipine and Atorvastatin | Alembic Pharmaceuticals Inc. | 2025-05-23 |
| 62332-0756-90 | 90 TABLET, FILM COATED in 1 BOTTLE (62332-756-90) | Amlodipine and Atorvastatin | Alembic Pharmaceuticals Inc. | 2025-05-23 |
Observed labelers:
Dr. Reddy's Laboratories Inc (44) ·
Alembic Pharmaceuticals Inc. (22) ·
Alembic Pharmaceuticals Limited (22) ·
Prasco Laboratories (11) ·
Apotex Corp. (8) ·
Mylan Pharmaceuticals Inc. (8)
· +3 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.